While unexpected, it is potentially related to the hyperlipidemic nature of these atherosclerotic models and alterations to classical LDL clearance, which is consistent with statins typically not yielding robust reductions in atherosclerosis or serum LDL in the ApoE−/− mouse model.34 This evidence concerns the gene APOE and atherosclerosis.